Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2000 1
2003 1
2006 1
2010 2
2011 2
2014 4
2015 4
2016 1
2017 4
2018 4
2019 5
2020 1
2021 3
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Survival and treatment of cranial and spinal chordomas: a population-based study.
Zhang GJ, Cui YS, Li H. Zhang GJ, et al. Neurosurg Rev. 2022 Feb;45(1):637-647. doi: 10.1007/s10143-021-01583-5. Epub 2021 Jun 22. Neurosurg Rev. 2022. PMID: 34156550
A total of 1797 patients were initially enrolled, including 762 (42.4%) cranial and 1035 (57.6%) spinal chordoma. A total of 1504 patients were further evaluated after screening. ...
A total of 1797 patients were initially enrolled, including 762 (42.4%) cranial and 1035 (57.6%) spinal chordoma. A total of 1 …
Prognostic factors in spinal chordoma: A systematic review.
Zou MX, Huang W, Wang XB, Li J, Lv GH, Deng YW. Zou MX, et al. Clin Neurol Neurosurg. 2015 Dec;139:110-8. doi: 10.1016/j.clineuro.2015.09.012. Epub 2015 Sep 25. Clin Neurol Neurosurg. 2015. PMID: 26432656 Review.
OBJECTIVE: Discovering reliable prognostic factors for spinal chordoma remains a challenge. We attempted to identify evidence-based prognostic factors in the literature since its inception and to establish pooled relative risks (RR) of such factors. METHODS: MEDLINE …
OBJECTIVE: Discovering reliable prognostic factors for spinal chordoma remains a challenge. We attempted to identify evidence- …
Immunohistochemical markers predicting long-term recurrence following clival and spinal chordoma resection: a multicenter study.
Ghaith AK, Akinduro OO, Alexander AY, Goyal A, Bon-Nieves A, de Macedo Filho L, Otamendi-Lopez A, Nathani KR, Abode-Iyamah K, Jentoft ME, Bendok BR, Clarke MJ, Link MJ, Van Gompel JJ, Quiñones-Hinojosa A, Bydon M. Ghaith AK, et al. Neurosurg Focus. 2023 Jun;54(6):E15. doi: 10.3171/2023.3.FOCUS22653. Neurosurg Focus. 2023. PMID: 37552641
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T, Gutman T, Hamza A, Adle-Biassette H, Girard E, Beaurepere R, Tariq Z, Mariani O, Dahmani A, Bourneix C, Abbritti R, Driouch K, Bohec M, Servant N, Baulande S, Decaudin D, Guichard JP, Calugaru V, Feuvret L, Guinebretière JM, Champion L, Bièche I, Froelich S, Mammar H, Masliah-Planchon J. Passeri T, et al. J Neurosurg. 2023 Apr 7;139(5):1270-1280. doi: 10.3171/2023.1.JNS222180. Print 2023 Nov 1. J Neurosurg. 2023. PMID: 37029667
METHODS: The authors conducted whole-exome sequencing (WES), targeted next-generation sequencing, and RNA sequencing of 64 skull base and spinal chordoma samples collected between December 2006 and September 2020. ...
METHODS: The authors conducted whole-exome sequencing (WES), targeted next-generation sequencing, and RNA sequencing of 64 skull base and …
Radiotherapy after gross-total resection and subtotal resection of spinal chordoma: a SEER database analysis of overall survival outcomes.
Gendreau J, Kuo CC, Mehkri Y, Chakravarti S, Lu B, Lubelski D, Redmond KJ, Bettegowda C, Mukherjee D. Gendreau J, et al. J Neurosurg Spine. 2023 Jun 9;39(3):411-418. doi: 10.3171/2023.5.SPINE2396. Print 2023 Sep 1. J Neurosurg Spine. 2023. PMID: 37327146
Given that RT may negatively impact patient quality of life, the aim of this study was to evaluate the utility of RT for improving OS in patients who have undergone GTR of spinal chordoma through analysis of the national Surveillance, Epidemiology, and End Results ( …
Given that RT may negatively impact patient quality of life, the aim of this study was to evaluate the utility of RT for improving OS in pat …
Clinicopathologic implications of CD8(+)/Foxp3(+) ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients.
Zou MX, Guo KM, Lv GH, Huang W, Li J, Wang XB, Jiang Y, She XL. Zou MX, et al. Cancer Immunol Immunother. 2018 Feb;67(2):209-224. doi: 10.1007/s00262-017-2080-1. Epub 2017 Oct 20. Cancer Immunol Immunother. 2018. PMID: 29051990 Free PMC article.
We aimed to analyze the relationship between PD-L1, miR-574-3p, microenvironmental tumor-infiltrating lymphocytes (TILs) and clinicopathological features of spinal chordoma patients. PD-L1 expression and TILs (including Foxp3(+), CD8(+), PD-1(+) and PD-L1(+)) were a …
We aimed to analyze the relationship between PD-L1, miR-574-3p, microenvironmental tumor-infiltrating lymphocytes (TILs) and clinicopatholog …
Management of Locally Recurrent Chordoma of the Mobile Spine and Sacrum: A Systematic Review.
Ailon T, Torabi R, Fisher CG, Rhines LD, Clarke MJ, Bettegowda C, Boriani S, Yamada YJ, Kawahara N, Varga PP, Shin JH, Saghal A, Gokaslan ZL. Ailon T, et al. Spine (Phila Pa 1976). 2016 Oct 15;41 Suppl 20(Suppl 20):S193-S198. doi: 10.1097/BRS.0000000000001812. Spine (Phila Pa 1976). 2016. PMID: 27753782 Free PMC article. Review.
OBJECTIVE: To determine evidence-based guidelines for the management of locally recurrent spinal chordoma. SUMMARY OF BACKGROUND DATA: Chordoma of the spine is a low-grade malignant tumor with a strong propensity for local recurrence. ...
OBJECTIVE: To determine evidence-based guidelines for the management of locally recurrent spinal chordoma. SUMMARY OF BACKGROU …
The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma.
Zou MX, Zheng BW, Liu FS, Wang XB, Hu JR, Huang W, Dai ZH, Zhang QS, Liu FB, Zhong H, Jiang Y, She XL, Li XB, Lv GH, Li J. Zou MX, et al. Neurosurgery. 2019 Dec 1;85(6):E1095-E1110. doi: 10.1093/neuros/nyz333. Neurosurgery. 2019. PMID: 31501892
BACKGROUND: Currently, little is known about the clinical relevance of tumor-stroma ratio (TSR) in chordoma and data discussing the relationship between TSR and immune status of chordoma are lacking. OBJECTIVE: To characterize TSR distribution in spinal chordoma, an …
BACKGROUND: Currently, little is known about the clinical relevance of tumor-stroma ratio (TSR) in chordoma and data discussing the relation …
Chordomas: Histopathological Study in View of Anatomical Location.
Cha YJ, Suh YL. Cha YJ, et al. J Korean Med Sci. 2019 Apr 8;34(13):e107. doi: 10.3346/jkms.2019.34.e107. J Korean Med Sci. 2019. PMID: 30950252 Free PMC article.
However, the histopathological and clinical differences between skull base chordoma (SBC) and sacral/spinal chordoma (SC) are unclear as previous studies have been focused on patient prognosis and treatment outcome. ...
However, the histopathological and clinical differences between skull base chordoma (SBC) and sacral/spinal chordoma (SC) are …
38 results